vTv Therapeutics Inc. (VTVT) › Cash & EquivalentsvTv Therapeutics Inc. (VTVT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $2.12M2013: $1.09M2014: $1.38M2015: $88.00M2016: $51.51M2017: $11.76M2018: $1.68M2019: $1.78M2020: $5.75M2021: $13.41M2022: $12.13M2023: $9.45M2024: $36.75M2025: $88.93M$88.93M2012Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$88.93M+142.0%2024$36.75M+289.0%2023$9.45M-22.1%2022$12.13M-9.6%2021$13.41M+133.4%2020$5.75M+223.4%2019$1.78M+5.6%2018$1.68M-85.7%2017$11.76M-77.2%2016$51.51M-41.5%2015$88.00M+6258.6%2014$1.38M+27.1%2013$1.09M-48.7%2012$2.12M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share